A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants with or without Elevated Lipoprotein (a) (Lp[a]) Levels.

Trial Identifier:	D7300C00001
Sponsor:	AstraZeneca
Start Date:	May 2025
Primary Completion Date:	December 2026
Study Completion Date:	December 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Glendale, CA, US, 91206
US, FL	Inverness, FL, US, 34452
US, FL	Jacksonville, FL, US, 32216
US, MD	Brooklyn, MD, US, 21225
US, TX	San Antonio, TX, US, 78229

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company